Evidence map›Paper›PMID 24271089›Full record

ReviewJournal of industrial microbiology & biotechnology2014

Genomics-enabled discovery of phosphonate natural products and their biosynthetic pathways.

Kou-San Ju, James R Doroghazi, William W Metcalf

Abstract readReview
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Discovery of the Phosphonate Flavophos Produced byJournal of the American Chemical Society · 2026
    Article
  5. Discovery of the Phosphonate Flavophos Produced bybioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Biosynthesis ofACS chemical biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Targeting Bacterial Genomes for Natural Product Discovery.Trends in pharmacological sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kou-San JuInstitute for Genomic Biology, University of Illinois, Urbana-Champaign, IL, 61801, USA.
James R Doroghazi
William W Metcalf

Funding

Structural Elucidation and Biosynthesis P01GM077596 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI EVANS, BRADLEY S. · 2007 to 2016
$15.3M
Discovery and Characterization of Novel Nitroaromatic AntibioticsF32GM100658 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI JU, KOU-SAN · 2012 to 2012
$52k
NIGMS NIH HHS F32 GM100658NIGMS NIH HHS F32GM100658NIGMS NIH HHS P01 GM077596NIGMS NIH HHS P01GM077596
6 · The paper itself

Abstract

Phosphonate natural products have proven to be a rich source of useful pharmaceutical, agricultural, and biotechnology products, whereas study of their biosynthetic pathways has revealed numerous intriguing enzymes that catalyze unprecedented biochemistry. Here we review the history of phosphonate natural product discovery, highlighting technological advances that have played a key role in the recent advances in their discovery. Central to these developments has been the application of genomics, which allowed discovery and development of a global phosphonate metabolic framework to guide research efforts. This framework suggests that the future of phosphonate natural products remains bright, with many new compounds and pathways yet to be discovered.

Indexed as

Biological ProductsBiosynthetic PathwaysGenomicsOrganophosphonatesBiological ProductsOrganophosphonates

Identifiers

PMID24271089
PMCPMC3946943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.